Józef Mizera

Józef Mizera

Auto-generated profile, based on publicly available information

Józef Mizera

Department of Toxicology, Jagiellonian University Medical College, Kraków, Poland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Behavioural Brain Research
Verified
Journal Article
Closed access
ENEwa Niedzielska-Andres
Ewa Niedzielska-Andres
JMJózef Mizera
Józef Mizera
ASAnna Sadakierska-Chudy
Anna Sadakierska-Chudy
LPLucyna Pomierny-Chamioło
Lucyna Pomierny-Chamioło
MFMałgorzata Filip
Małgorzata Filip

1 October 2017 in Pharmacological Reports
Verified
Journal Article
Closed access
LPLucyna Pomierny-Chamioło
Lucyna Pomierny-Chamioło
JMJoanna Miszkiel
Joanna Miszkiel
MFMalgorzata Frankowska
Malgorzata Frankowska
JMJózef Mizera
Józef Mizera
MFMałgorzata Filip
Małgorzata Filip

2 April 2024 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
MSMarta Szwajca
Marta Szwajca
GKGrzegorz Kazek
Grzegorz Kazek
NŚNatalia Śmierciak
Natalia Śmierciak
JMJózef Mizera
Józef Mizera
LPLucyna Pomierny-Chamioło
Lucyna Pomierny-Chamioło
MPMaciej Pilecki
Maciej Pilecki
Aim: Schizophrenia involves complex interactions between biological and environmental factors, including childhood trauma, cognitive impairments, and premorbid adjustment. Predicting its severity and progression remains challenging. Biomarkers like glial cell line-derived neurotrophic factor (GDNF) and miRNA-29a may bridge biological and environmental aspects. The goal was to explore the connections between miRNAs and neural proteins and cognitive functioning, childhood trauma, and premorbid adjustment in the first episode of psychosis (FEP).Method: This study included 19 FEP patients who underwent clinical evaluation with: the Childhood Trauma Questionnaire (CTQ), the Premorbid Adjustment Scale (PAS), the Positive and Negative Syndrome Scale (PANSS), and the Montreal Cognitive Assessment Scale (MoCA). Multiplex assays for plasma proteins were conducted with Luminex xMAP technology. Additionally, miRNA levels were quantitatively determined through RNA extraction, cDNA synthesis, and RT-qPCR on a 7500 Fast Real-Time PCR System.Results: Among miRNAs, only miR-29a-3p exhibited a significant correlation with PAS-C scores (r = -0.513, p = 0.025) and cognitive improvement (r = -0.505, p = 0.033). Among the analyzed proteins, only GDNF showed correlations with MoCA scores at the baseline and after 3 months (r = 0.533, p = 0.0189 and r = 0.598, p = 0.007), cognitive improvement (r = 0.511, p = 0.025), and CTQ subtests. MIF concentrations correlated with the PAS-C subscale (r = -0.5670, p = 0.011).Conclusion: GDNF and miR-29a-3p are promising as biomarkers for understanding and addressing cognitive deficits in psychosis. This study links miRNA and MIF to premorbid adjustment and reveals GDNF’s unique role in connection with childhood trauma.

22 April 2024 in Pharmacological Reports
Verified
Journal Article
Open access
PDF file
MKMagdalena Kacperska
Magdalena Kacperska
JMJózef Mizera
Józef Mizera
MPMaciej Pilecki
Maciej Pilecki
LPLucyna Pomierny-Chamioło
Lucyna Pomierny-Chamioło
The global prevalence of overweight and obesity is a significant public health concern that also largely affects women of childbearing age. Human epidemiological studies indicate that prenatal exposure to excessive maternal weight or excessive gestational weight gain is linked to various neurodevelopmental disorders in children, including attention deficit hyperactivity disorder, autism spectrum disorder, internalizing and externalizing problems, schizophrenia, and cognitive/intellectual impairment. Considering that inadequate maternal body mass can induce serious disorders in offspring, it is important to increase efforts to prevent such outcomes. In this paper, we review human studies linking excessive maternal weight and the occurrence of mental disorders in children.